XML 70 R24.htm IDEA: XBRL DOCUMENT
v2.4.1.9

SEGMENT INFORMATION | 12 Months Ended
--- | ---
Dec. 31, 2014
SEGMENT INFORMATION |
SEGMENT INFORMATION | NOTE 17 SEGMENT INFORMATION The Company operates in the packaging components industry, which includes the development, manufacture and sale of consumer product dispensing solutions. The Company is organized into three reporting segments. Operations that sell dispensing solutions primarily to the personal care, beauty and home care markets form the Beauty + Home segment. Operations that sell dispensing solutions to the prescription drug, consumer health care and injectables markets form the Pharma segment. Operations that sell dispensing solutions primarily to the food and beverage markets form the Food + Beverage segment. The accounting policies of the segments are the same as those described in Note 1, Summary of Significant Accounting Policies. The Company evaluates performance of its business segments and allocates resources based upon segment income. Segment income is defined as earnings before net interest expense, certain corporate expenses, restructuring initiatives and income taxes. Financial information regarding the Company's reportable segments is shown below:
Years Ended December 31, |  | 2014 |  | 2013 |  | 2012 |
Total Sales: |  |  |  |  |  |  |  |  |  |
Beauty + Home |  | $ | 1,522,444 |  | $ | 1,501,611 |  | $ | 1,468,599 |
Pharma |  |  | 751,226 |  |  | 709,058 |  |  | 588,853 |
Food + Beverage |  |  | 349,297 |  |  | 323,469 |  |  | 288,995 |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total Sales |  | $ | 2,622,967 |  | $ | 2,534,138 |  | $ | 2,346,447 |
Less: Intersegment Sales: |  |  |  |  |  |  |  |  |  |
Beauty + Home |  | $ | 24,147 |  | $ | 13,466 |  | $ | 14,659 |
Pharma |  |  | — |  |  | 284 |  |  | 160 |
Food + Beverage |  |  | 1,011 |  |  | 375 |  |  | 592 |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total Intersegment Sales |  | $ | 25,158 |  | $ | 14,125 |  | $ | 15,411 |
Net Sales: |  |  |  |  |  |  |  |  |  |
Beauty + Home |  | $ | 1,498,297 |  | $ | 1,488,145 |  | $ | 1,453,940 |
Pharma |  |  | 751,226 |  |  | 708,774 |  |  | 588,693 |
Food + Beverage |  |  | 348,286 |  |  | 323,094 |  |  | 288,403 |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net Sales |  | $ | 2,597,809 |  | $ | 2,520,013 |  | $ | 2,331,036 |
Segment Income (1): |  |  |  |  |  |  |  |  |  |
Beauty + Home |  | $ | 98,368 |  | $ | 109,272 |  | $ | 123,527 |
Pharma |  |  | 204,698 |  |  | 189,689 |  |  | 141,912 |
Food + Beverage |  |  | 37,728 |  |  | 35,186 |  |  | 30,415 |
Restructuring Initiatives and Related Depreciation |  |  | — |  |  | (14,525 | ) |  | (4,678 | )
Corporate & Other |  |  | (38,261 | ) |  | (37,958 | ) |  | (33,849 | )
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Income before interest and taxes |  | $ | 302,533 |  | $ | 281,664 |  | $ | 257,327 |
Interest expense, net |  |  | (16,232 | ) |  | (17,281 | ) |  | (15,954 | )
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Income before income taxes |  | $ | 286,301 |  | $ | 264,383 |  | $ | 241,373 |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Depreciation and Amortization (1): |  |  |  |  |  |  |  |  |  |
Beauty + Home |  | $ | 85,469 |  | $ | 83,328 |  | $ | 82,828 |
Pharma |  |  | 41,690 |  |  | 39,812 |  |  | 33,122 |
Food + Beverage |  |  | 20,179 |  |  | 18,871 |  |  | 15,605 |
Restructuring Initiatives |  |  | — |  |  | 2,725 |  |  | 1,576 |
Corporate & Other |  |  | 4,880 |  |  | 5,220 |  |  | 3,891 |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Depreciation and Amortization |  | $ | 152,218 |  | $ | 149,956 |  | $ | 137,022 |
Capital Expenditures: |  |  |  |  |  |  |  |  |  |
Beauty + Home |  | $ | 76,544 |  | $ | 81,247 |  | $ | 97,010 |
Pharma |  |  | 37,455 |  |  | 32,643 |  |  | 24,953 |
Food + Beverage |  |  | 32,148 |  |  | 19,339 |  |  | 32,282 |
Corporate & Other |  |  | 15,793 |  |  | 18,281 |  |  | 19,808 |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Capital Expenditures |  | $ | 161,940 |  | $ | 151,510 |  | $ | 174,053 |
Total Assets: |  |  |  |  |  |  |  |  |  |
Beauty + Home |  | $ | 1,193,370 |  | $ | 1,318,933 |  | $ | 1,240,101 |
Pharma |  |  | 619,304 |  |  | 676,420 |  |  | 659,132 |
Food + Beverage |  |  | 263,742 |  |  | 253,774 |  |  | 233,553 |
Corporate & Other |  |  | 360,774 |  |  | 248,635 |  |  | 191,626 |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total Assets |  | $ | 2,437,190 |  | $ | 2,497,762 |  | $ | 2,324,412 |
(1) | The Company evaluates performance of its business units and allocates resources based upon segment income. Segment income is defined as earnings before net interest expense, certain corporate expenses, restructuring initiatives and income taxes. Restructuring Initiatives and related Depreciation includes the following income/(expense) items for the twelve months ended December 31, 2014, 2013 and 2012 as follows:
Years Ended December 31, |  | 2014 |  | 2013 |  | 2012 |
European Restructuring Plan |  |  |  |  |  |  |  |  |  |
Depreciation |  | $ | — |  | $ | 2,725 |  | $ | 1,576 |
Employee Severance and Other Costs |  |  | — |  |  | 11,844 |  |  | 3,314 |
Prior Year Initiatives |  |  | — |  |  | (44 | ) |  | (212 | )
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total Restructuring Initiatives and Related Depreciation Expense |  | $ | — |  | $ | 14,525 |  | $ | 4,678 |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Restructuring Initiatives and Related Depreciation Expense by Segment |  |  |  |  |  |  |  |  |  |
Beauty + Home |  | $ | — |  | $ | 14,548 |  | $ | 4,787 |
Pharma |  |  | — |  |  | — |  |  | — |
Food + Beverage |  |  | — |  |  | (23 | ) |  | (109 | )
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total Restructuring Initiatives and Related Depreciation Expense |  | $ | — |  | $ | 14,525 |  | $ | 4,678 |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
GEOGRAPHIC INFORMATION The following are net sales and long-lived asset information by geographic area and product information for the years ended December 31, 2014, 2013 and 2012:
|  | 2014 |  | 2013 |  | 2012 |
Net Sales to Unaffiliated Customers (1): |  |  |  |  |  |  |  |  |  |
United States |  | $ | 642,060 |  | $ | 634,418 |  | $ | 650,637 |
Europe: |  |  |  |  |  |  |  |  |  |
France |  |  | 850,817 |  |  | 810,528 |  |  | 650,226 |
Germany |  |  | 363,898 |  |  | 339,858 |  |  | 311,205 |
Italy |  |  | 141,808 |  |  | 136,617 |  |  | 144,163 |
Other Europe |  |  | 150,469 |  |  | 165,038 |  |  | 163,695 |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total Europe |  |  | 1,506,992 |  |  | 1,452,041 |  |  | 1,269,289 |
Other Foreign Countries |  |  | 448,757 |  |  | 433,554 |  |  | 411,110 |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total |  | $ | 2,597,809 |  | $ | 2,520,013 |  | $ | 2,331,036 |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Plant, Property & Equipment: |  |  |  |  |  |  |  |  |  |
United States |  | $ | 192,265 |  | $ | 226,917 |  | $ | 191,697 |
Europe: |  |  |  |  |  |  |  |  |  |
France |  |  | 228,049 |  |  | 263,913 |  |  | 251,015 |
Germany |  |  | 136,491 |  |  | 156,970 |  |  | 137,203 |
Italy |  |  | 48,940 |  |  | 57,729 |  |  | 65,743 |
Other Europe |  |  | 57,946 |  |  | 72,297 |  |  | 72,404 |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total Europe |  |  | 471,426 |  |  | 550,909 |  |  | 526,365 |
Other Foreign Countries |  |  | 147,964 |  |  | 86,836 |  |  | 130,171 |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total |  | $ | 811,655 |  | $ | 864,662 |  | $ | 848,233 |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Product Net Sales Information: |  |  |  |  |  |  |  |  |  |
Pumps |  | $ | 1,111,536 |  | $ | 1,093,514 |  | $ | 1,044,226 |
Closures |  |  | 611,144 |  |  | 594,135 |  |  | 605,493 |
Valves |  |  | 350,106 |  |  | 327,635 |  |  | 327,251 |
Injectables (2) |  |  | 143,631 |  |  | 142,116 |  |  | 56,465 |
Other |  |  | 381,392 |  |  | 362,613 |  |  | 297,601 |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total |  | $ | 2,597,809 |  | $ | 2,520,013 |  | $ | 2,331,036 |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
(1) | Sales are attributed to countries based upon where the sales invoice to unaffiliated customers is generated.
(2) | Injectables represent six month sales in 2012 from the date of acquisition.
No single customer represents 10% or more of the Company's net sales in 2014, 2013 or 2012.

X
- Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 35 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 33 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration